Pfizer

News

EU probes low platelet safety signal with COVID-19 shots

EU regulators are reviewing reports of low blood platelets in patients who received any of the three approved COVID-19 vaccines from Pfizer/BioNTech, AstraZeneca and Moderna.

News

Pfizer/BioNTech COVID jab works against Brazil variant; lab ...

A laboratory study suggests Pfizer and BioNTech’s COVID-19 vaccine Comirnaty could be effective against a Brazilian variant of the SARS-CoV-2 virus – known as P.1 – that is worrying health

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J manufacturing delays hit US vaccine rollout

The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available.

News

Data back use of AZ and Pfizer COVID-19 vaccines in older pe...

Both the Pfizer/BioNTech and Oxford University/AstraZeneca COVID-19 vaccines are highly effective in reducing COVID-19 infections among older people, according to an emerging study data.

News

Parasitic biting insect on background of epidermis detail. Disgusting carrier of encephalitis, Lyme disease or babesiosis infections. Tick-borne diseases

Pfizer files tick-borne encephalitis shot with FDA

Pfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the only infectious disease the big pharma is targeting.

News

Scientists make case for one dose of Pfizer’s COVID jab to s...

Two researchers have suggested that the second dose of Pfizer and BioNTech’s COVID-19 vaccine could be delayed, as this would increase the number of people that can be protected while suppl

EU probes low platelet safety signal with COVID-19 shots

Pfizer/BioNTech COVID jab works against Brazil variant; lab ...

J&J manufacturing delays hit US vaccine rollout

Data back use of AZ and Pfizer COVID-19 vaccines in older pe...

Pfizer files tick-borne encephalitis shot with FDA

Scientists make case for one dose of Pfizer’s COVID jab to s...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks